摘要
目的探讨参麦注射液治疗煤工尘肺合并呼吸衰竭的临床疗效。方法选取医院2010年9月至2011年9月收治的煤工尘肺合并呼吸衰竭患者90例,随机分成观察组和对照组各45例。两组患者经过相关检查和明确诊断后均进行西医一般常规治疗,观察组患者在此基础上加用参麦注射液治疗。结果与对照组相比,观察组救治成功的比例显著提高,组间比较差异具有统计学意义(P<0.05)。与此同时,观察组患者氧分压和二氧化碳分压等动脉血气分析指标均显著改善,且组间比较差异均具有统计学意义(P<0.05)。结论参麦注射液可提高煤工尘肺合并呼吸衰竭患者的临床疗效,值得临床推广。
Objective To probe into the clinical effect of Shenmai Injection in the treatment of pneumoconiosis combined with respiratory failure in coal workers.Methods 90 patients with pneumoconiosis combined with respiratory failure in our hospital from September 2010 to September 2011 were selected and divided into the observation group and the control group randomly,45 cases in each group.All the patients in the two groups were performed the general conventional Western medicine treatment after the relevant examinations and diagnosis.On this base,the observation group was added with Shenmai Injection.The clinical conditions and blood gas analysis in the two groups were compared and analyzed.Results Compared with the control group,the effective rate in the observation group was significantly increased with statistical difference between the two groups（P 〈 0.05）.At the same time,the arterial blood gas indicators of PaO2 and PaCO2 in the observation group were significantly improved,also showing statistical difference between the two groups（P 〈 0.05）.Conclusion Shenmai Injection has important actual meaning for improving the clinical effects in coal workers with pneumoconiosis complicating respiratory failure and deserves to be further promoted in clinic.
出处
《中国药业》
CAS
2012年第12期95-96,共2页
China Pharmaceuticals
关键词
煤工
尘肺
呼吸衰竭
参麦注射液
coal workers
pneumoconiosis
respiratory failure
Shenmai Injection
